Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dima M Qato

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
JAMA|September 10, 2024
Pharmacy Benefit Manager Market Concentration for Prescriptions Filled at US Retail PharmaciesDima M Qato, Yugen Chen, Karen Van Nuys
JAMA Health Forum|October 11, 2022
Federal and State Pharmacy Regulations and Dispensing Barriers to Buprenorphine Access at Retail Pharmacies in the USDima M Qato, Jonathan H Watanabe, Kelly J Clark
JAMA|July 22, 2020
Use of Risk Evaluation and Mitigation Strategies by the US Food and Drug Administration, 2008-2019Jenny S Guadamuz, Dima M Qato, G Caleb Alexander
AIDS and Behavior|September 26, 2023
Changes in HIV Pre-exposure Prophylaxis (PrEP) Coverage at State and County Level During the COVID-19 Pandemic in the United StatesMahdi Fallahi, Jenny S Guadamuz, Andrew Shooshtari, et al.
Preventing Chronic Disease|September 5, 2020
Telepharmacy and Quality of Medication Use in Rural Areas, 2013-2019Shweta Pathak, Mitchell Haynes, Dima M Qato, et al.
Drug and Alcohol Dependence|January 16, 2022
Changes in the availability of medications for opioid use disorder in prisons and jails in the United States during the COVID-19 pandemicDavid Dadiomov, Rebecca Trotzky-Sirr, Andrew Shooshtari, et al.
JAMA Health Forum|August 2, 2024
Prescription Fills for Semaglutide Products by Payment MethodChristopher Scannell, John Romley, Rebecca Myerson, et al.
JAMA|July 24, 2023
Insulin Fills by Medicare Enrollees and Out-of-Pocket Caps Under the Inflation Reduction ActRebecca Myerson, Dima M Qato, Dana P Goldman, et al.
Pharmacoepidemiology and Drug Safety|August 26, 2021
Prevalence and distribution of high-risk prescription opioid use in the United States, 2011-2016Carter D McCormick, David Dadiomov, Rebecca Trotzky-Sirr, et al.
JAMA Network Open|May 26, 2023
Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the USScott G Weiner, Dima M Qato, Jeremy Samuel Faust, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
JAMA|September 10, 2024
Pharmacy Benefit Manager Market Concentration for Prescriptions Filled at US Retail PharmaciesDima M Qato, Yugen Chen, Karen Van Nuys
JAMA Health Forum|October 11, 2022
Federal and State Pharmacy Regulations and Dispensing Barriers to Buprenorphine Access at Retail Pharmacies in the USDima M Qato, Jonathan H Watanabe, Kelly J Clark
JAMA|July 22, 2020
Use of Risk Evaluation and Mitigation Strategies by the US Food and Drug Administration, 2008-2019Jenny S Guadamuz, Dima M Qato, G Caleb Alexander
AIDS and Behavior|September 26, 2023
Changes in HIV Pre-exposure Prophylaxis (PrEP) Coverage at State and County Level During the COVID-19 Pandemic in the United StatesMahdi Fallahi, Jenny S Guadamuz, Andrew Shooshtari, et al.
Preventing Chronic Disease|September 5, 2020
Telepharmacy and Quality of Medication Use in Rural Areas, 2013-2019Shweta Pathak, Mitchell Haynes, Dima M Qato, et al.
Drug and Alcohol Dependence|January 16, 2022
Changes in the availability of medications for opioid use disorder in prisons and jails in the United States during the COVID-19 pandemicDavid Dadiomov, Rebecca Trotzky-Sirr, Andrew Shooshtari, et al.
JAMA Health Forum|August 2, 2024
Prescription Fills for Semaglutide Products by Payment MethodChristopher Scannell, John Romley, Rebecca Myerson, et al.
JAMA|July 24, 2023
Insulin Fills by Medicare Enrollees and Out-of-Pocket Caps Under the Inflation Reduction ActRebecca Myerson, Dima M Qato, Dana P Goldman, et al.
Pharmacoepidemiology and Drug Safety|August 26, 2021
Prevalence and distribution of high-risk prescription opioid use in the United States, 2011-2016Carter D McCormick, David Dadiomov, Rebecca Trotzky-Sirr, et al.
JAMA Network Open|May 26, 2023
Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the USScott G Weiner, Dima M Qato, Jeremy Samuel Faust, et al.
Pageof 8